Latest Post

***< 0 We generated a heterodimeric Fc fusion protein, GBP1+6-Fc, by separately fusing GBP1 and GBP6 to oppositely polarized Fc fragments that can only bind to each other and not homodimerically (Fig 2C)

Most affected patients exhibit a marked reduction of serum immunoglobulins, mature B cells, and an increased susceptibility to recurrent bacterial infections. was not diagnosed until B-lymphocyte surface antigen Anandamide studies and a genetic analysis were conducted. Conclusions We suggest that B-lymphocyte surface antigen studies and a BTK mutation analysis should be performed in familial patients with selective IgM deficiency to rule out atypical XLA. Keywords: X-linked agammaglobulinaemia, Brutons tyrosine kinase, Proteinuria, Haematuria, Immunoglobulin Background X-linked agammaglobulinaemia (XLA) (OMIM # 300755) is usually a humoural immunodeficiency disease characterised by severe hypogammaglobulinaemia, defective B cell development, and extremely decreased numbers of mature B cells [1]. In 1952, Colonel Ogden Bruton explained the first case of XLA in a young man with a history of recurrent bacterial infections [2]. The gene responsible for XLA was recognized in 1993 and named Brutons tyrosin kinase (BTK) [3]. The gene is usually localised at Xq21.3-Xq22 and contains 19 exons spanning 37.5?kb Anandamide [4]. A member of the Tec family, the gene is usually a cytoplasmic tyrosine kinase that plays a critical role in the development of B cells [5]. Five domains of BTK, comprising pleckstrin homology (PH), Tec homology (TH), Src homology 3 (SH3), Src homology 2 (SH2), and the kinase domain name TK, have been recognized, with each having a distinctive function [5]. The lack of functional BTK results in defective B cell development at the pro-B and pre-B cell stages [6], leading to a reduction of mature B cells in the peripheral blood. The clinical diagnosis of XLA depends on a positive family history of immunodeficiency, recurrent bacterial Rabbit polyclonal to HIP infections before the age of 5?years, life-threatening bacterial infections in early child years, and considerably low levels of all isotypes of serum immunoglobulins [7]. These indications are necessary for a definite diagnosis of XLA: the patient must be male and have less than 2% CD19+ B cells with mutations in the gene, absent BTK mRNA on a northern blot analysis of neutrophils or monocytes, absent BTK proteins in monocytes or platelets, Anandamide as well as maternal cousins, uncles, or nephews who have mutations [8]. Most XLA-afflicted boys were diagnosed with repeated or protracted bacterial infections during early child years after their maternal immunoglobulins had been lost [9], and before the era of the intravenous immunoglobulin (IVIG) and antibiotics, the disease could be life threatening. Currently, only 2 XLA cases associated with nephropathies can be found in the literature [10,11]. Here, we statement an atypical XLA case occurring with a novel mutation in a Chinese young man presenting with nephritis and selective IgM deficiency. Case presentation A 6-year-old Chinese young man with a 2-12 months history of persistent haematuria and proteinuria found by routine screen was referred to our department. He had suffered several episodes of otitis media and maxillary sinusitis since the age of 3?years without requiring hospitalisation. He was diagnosed with selective IgM deficiency at the age of 5?years. Clinical examinations revealed a normal gross appearance and growth percentile, and there was no pitting edema or skin rash. His family history was unremarkable except that his elder brother, who experienced experienced recurrent sinusitis and atopic dermatitis, had been diagnosed with selective IgM deficiency at the age of 3?years. His brother experienced received intravenous immunoglobulin (IVIG) treatments and has normal renal function without proteinuria and haematuria. Examining our patients kidneys by using ultrasound revealed that his kidneys and urinary tract system were grossly normal. Performing a dipstick urinalysis revealed that this urine contained occult blood 3+ and protein 2+. His daily protein loss was 1.4?g/d. Other blood and urine biochemistry data, including titres of the antinuclear antibodies, antistreptolysin-O, and autoantibodies related to systemic lupus erythematosus were all unfavorable (Table? 1). Table 1 Clinical characteristics of our patients with X-linked agammaglobulinemia gene revealed that the patient and his brother both exhibited a c.347C?>?T (p.P116L) mutation inherited from their mother (Physique? 3). After a 2-12 months follow up, our patient remains proteinuria-free with normal kidney.